Proteomic profiling of Pseudomonas aeruginosa AES-1R, PAO1 and PA14 reveals potential virulence determinants associated with a transmissible cystic fibrosis-associated strain

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Hare, Nathan J ^a   Solis, Nestor ^a   Harmer, Christopher ^a   Marzook, N Bishara ^a   Rose, Barbara ^a   Harbour, Colin ^a   Crossett, Ben ^a   Manos, Jim ^a   Cordwell, Stuart J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CARBOHYDRATE BINDING PROTEIN; FATTY ACID; GLYCOPROTEIN; IRON; SIDEROPHORE; PROTEOME; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOSYNTHESIS; CYSTIC FIBROSIS; FATTY ACID SYNTHESIS; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; PSEUDOMONAS AERUGINOSA; CHEMISTRY; COMPARATIVE STUDY; DISEASE TRANSMISSION; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PSEUDOMONAS INFECTION; VIRULENCE; WOUND INFECTION;

PSEUDOMONAS AERUGINOSA;

AUSTRALIA; BACTERIAL PROTEINS; CYSTIC FIBROSIS; HUMANS; PROTEOME; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VIRULENCE; VIRULENCE FACTORS; WOUND INFECTION;

EID: 84855990633     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-16     Document Type: Article

References (77)

1. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, et al. Nature 2000 406 959 964 10.1038/35023079 10984043
2. Protein secretion systems in Pseudomonas aeruginosa: a wealth of pathogenic weapons. Bleves S, Viarre V, Salacha R, Michel GP, Filloux A, Voulhoux R, Int J Med Microbiol 2010 300 534 543 10.1016/j.ijmm.2010.08.005 20947426
3. Lung infections associated with cystic fibrosis. Lyczak JB, Cannon CL, Pier GB, Clin Microbiol Rev 2002 15 194 222 10.1128/CMR.15.2.194-222.2002 11932230 (Pubitemid 34303763)
4. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Boucher RC, Annu Rev Med 2007 58 157 170 10.1146/annurev.med.58.071905.105316 17217330 (Pubitemid 46706507)
5. Eradication of early Pseudomonas aeruginosa infection. Hoiby N, Frederiksen B, Pressler T, J Cyst Fibros 2005 4 Suppl 2 49 54 16023416 (Pubitemid 41131329)
6. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepaci. Govan JR, Deretic V, Microbiol Rev 1996 60 539 574 8840786 (Pubitemid 26303478)
7. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Armstrong DS, Nixon GM, Carzino R, Bigham A, Carlin JB, Robins-Browne RM, Grimwood K, Am J Respir Crit Care Med 2002 166 983 987 10.1164/rccm.200204-269OC 12359658 (Pubitemid 35193230)
8. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. O'Carroll MR, Syrmis MW, Wainwright CE, Greer RM, Mitchell P, Coulter C, Sloots TP, Nissen MD, Bell SC, Eur Respir J 2004 24 101 106 10.1183/09031936.04.00122903 15293611 (Pubitemid 39029075)
9. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population. Bradbury R, Champion A, Reid DW, Respirology 2008 13 886 892 10.1111/j.1440-1843.2008.01383.x 18811887
10. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, Webb AK, Lancet 2001 358 557 558 10.1016/S0140-6736(01)05714-2 11520529 (Pubitemid 32772734)
11. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Cheng K, Smyth RL, Govan JR, Doherty C, Winstanley C, Denning N, Heaf DP, van Saene H, Hart CA, Lancet 1996 348 639 642 10.1016/S0140-6736(96) 05169-0 8782753 (Pubitemid 26293808)
12. Worldwide distribution of Pseudomonas aeruginosa clone C strains in the aquatic environment and cystic fibrosis patients. Romling U, Kader A, Sriramulu DD, Simm R, Kronvall G, Environ Microbiol 2005 7 1029 1038 10.1111/j.1462-2920. 2005.00780.x 15946300 (Pubitemid 40817161)
13. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis. Aaron SD, Vandemheen KL, Ramotar K, Giesbrecht-Lewis T, Tullis E, Freitag A, Paterson N, Jackson M, Lougheed MD, Dowson C, et al. JAMA 2010 304 2145 2153 10.1001/jama.2010.1665 21081727
14. Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis. Wainwright CE, France MW, O'Rourke P, Anuj S, Kidd TJ, Nissen MD, Sloots TP, Coulter C, Ristovski Z, Hargreaves M, et al. Thorax 2009 64 926 931 10.1136/thx.2008.112466 19574243
15. An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis. Clifton IJ, Fletcher LA, Beggs CB, Denton M, Conway SP, Peckham DG, J Cyst Fibros 2010 9 64 68 10.1016/j.jcf.2009.11.004 19944655
16. A subtype of a Pseudomonas aeruginosa cystic fibrosis epidemic strain exhibits enhanced virulence in a murine model of acute respiratory infection. Carter ME, Fothergill JL, Walshaw MJ, Rajakumar K, Kadioglu A, Winstanley C, J Infect Dis 2010 202 935 942 10.1086/655781 20704484
17. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives. McCallum SJ, Gallagher MJ, Corkill JE, Hart CA, Ledson MJ, Walshaw MJ, Thorax 2002 57 559 560 10.1136/thorax.57.6.559 12037234 (Pubitemid 34627991)
18. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, et al. Proc Natl Acad Sci USA 2006 103 8487 8492 10.1073/pnas.0602138103 16687478 (Pubitemid 43838482)
19. Dynamics of Pseudomonas aeruginosa genome evolution. Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish JM, Koehrsen M, Rokas A, Yandava CN, Engels R, Zeng E, et al. Proc Natl Acad Sci USA 2008 105 3100 3105 10.1073/pnas.0711982105 18287045 (Pubitemid 351723674)
20. The accessory genome of Pseudomonas aeruginosa. Kung VL, Ozer EA, Hauser AR, Microbiol Mol Biol Rev 2010 74 621 641 10.1128/MMBR.00027-10 21119020
21. Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. Schmidt KD, Tummler B, Romling U, J Bacteriol 1996 178 85 93 8550447 (Pubitemid 26006069)
22. Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa. Parsons YN, Panagea S, Smart CH, Walshaw MJ, Hart CA, Winstanley C, J Clin Microbiol 2002 40 4607 4611 10.1128/JCM.40.12.4607-4611.2002 12454160 (Pubitemid 35434955)
23. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. Salunkhe P, Smart CH, Morgan JA, Panagea S, Walshaw MJ, Hart CA, Geffers R, Tummler B, Winstanley C, J Bacteriol 2005 187 4908 4920 10.1128/JB.187.14.4908-4920.2005 15995206 (Pubitemid 40962208)
24. Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum. Fung C, Naughton S, Turnbull L, Tingpej P, Rose B, Arthur J, Hu H, Harmer C, Harbour C, Hassett DJ, et al. J Med Microbiol 2010 59 1089 1100 10.1099/jmm.0.019984-0 20522626
25. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Son MS, Matthews WJ Jr, Kang Y, Nguyen DT, Hoang TT, Infect Immun 2007 75 5313 5324 10.1128/IAI.01807-06 17724070 (Pubitemid 350033619)
26. Common virulence factors for bacterial pathogenicity in plants and animals. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM, Science 1995 268 1899 1902 10.1126/science.7604262 7604262
27. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. Gobom J, Nordhoff E, Mirgorodskaya E, Ekman R, Roepstorff P, J Mass Spectrom 1999 34 105 116 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4 10093212
28. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Wessel D, Flugge UI, Anal Biochem 1984 138 141 143 10.1016/0003-2697(84)90782-6 6731838 (Pubitemid 14146660)
29. Mascot-derived false positive peptide identifications revealed by manual analysis of tandem mass spectra. Chen Y, Zhang J, Xing G, Zhao Y, J Proteome Res 2009 8 3141 3147 10.1021/pr900172v 19368407
30. Pseudomonas aeruginosa AES-1 exhibits increased virulence gene expression during chronic infection. Naughton S, Parker D, Seemann T, Thomas T, Turnbull L, Rose B, Bye P, Cordwell S, Whitchurch C, Manos J, PLoS One 2011 6 24526 10.1371/journal.pone.0024526 21935417
31. Detergent binding explains anomalous SDS-PAGE migration of membrane proteins. Rath A, Glibowicka M, Nadeau VG, Chen G, Deber CM, Proc Natl Acad Sci USA 2009 106 1760 1765 10.1073/pnas.0813167106 19181854
32. Investigation of charge variants of rViscumin by two-dimensional gel electrophoresis and mass spectrometry. Lutter P, Meyer HE, Langer M, Witthohn K, Dormeyer W, Sickmann A, Bluggel M, Electrophoresis 2001 22 2888 2897 10.1002/1522-2683(200108)22:14<2888::AID-ELPS2888>3.0.CO;2-C 11565784 (Pubitemid 32851186)
33. Mass spectrometric characterization of the Campylobacter jejuni adherence factor CadF reveals post-translational processing that removes immunogenicity while retaining fibronectin binding. Scott NE, Marzook NB, Deutscher A, Falconer L, Crossett B, Djordjevic SP, Cordwell SJ, Proteomics 2010 10 277 288 10.1002/pmic.200900440 19941310
34. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Jalal S, Ciofu O, Hoiby N, Gotoh N, Wretlind B, Antimicrob Agents Chemother 2000 44 710 712 10.1128/AAC.44.3.710-712.2000 10681343 (Pubitemid 30117966)
35. Iron uptake regulation in Pseudomonas aeruginosa. Cornelis P, Matthijs S, Van Oeffelen L, Biometals 2009 22 15 22 10.1007/s10534-008-9193-0 19130263
36. Proteomic comparison of membrane and extracellular proteins from invasive (PAO1) and cytotoxic (6206) strains of Pseudomonas aeruginosa. Nouwens AS, Willcox MDP, Walsh BJ, Cordwell SJ, Proteomics 2002 2 1325 1346 10.1002/1615-9861(200209)2:9<1325::AID-PROT1325>3.0.CO;2-4 12362351
37. Identification of quorum-sensing regulated proteins in the opportunistic pathogen Pseudomonas aeruginosa by proteomics. Arevalo-Ferro C, Hentzer M, Reil G, Gorg A, Kjelleberg S, Givskov M, Riedel K, Eberl L, Environ Microbiol 2003 5 1350 1369 10.1046/j.1462-2920.2003.00532.x 14641579 (Pubitemid 38038945)
38. Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa. Firoved AM, Deretic V, J Bacteriol 2003 185 1071 1081 10.1128/JB.185.3.1071-1081.2003 12533483 (Pubitemid 36139466)
39. A novel oxidized low-density lipoprotein-binding protein from Pseudomonas aeruginosa. Rao J, DiGiandomenico A, Unger J, Bao Y, Polanowska-Grabowska RK, Goldberg JB, Microbiology 2008 154 654 665 10.1099/mic.0.2007/011429-0 18227268 (Pubitemid 351292318)
40. Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation. Winklhofer-Roob BM, Ziouzenkova O, Puhl H, Ellemunter H, Greiner P, Muller G, van't Hof MA, Esterbauer H, Shmerling DH, Free Radic Biol Med 1995 19 725 733 10.1016/0891-5849(95)00063-4 8582644
41. Characterization of Pseudomonas aeruginosa chitinase, a gradually secreted protein. Folders J, Algra J, Roelofs MS, van Loon LC, Tommassen J, Bitter W, J Bacteriol 2001 183 7044 7052 10.1128/JB.183.24.7044-7052.2001 11717261 (Pubitemid 33121836)
42. Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions. Marquart ME, Caballero AR, Chomnawang M, Thibodeaux BA, Twining SS, O'Callaghan RJ, Invest Ophthalmol Vis Sci 2005 46 3761 3768 10.1167/iovs.04-1483 16186360 (Pubitemid 44264683)
43. Immunoproteomics to examine cystic fibrosis host interactions with extracellular Pseudomonas aeruginosa proteins. Upritchard HG, Cordwell SJ, Lamont IL, Infect Immun 2008 76 4624 4632 10.1128/IAI.01707-07 18663005
44. Redox warfare between airway epithelial cells and Pseudomonas: dual oxidase versus pyocyanin. Rada B, Leto TL, Immunol Res 2009 43 198 209 10.1007/s12026-008-8071-8 18979077
45. The Pseudomonas toxin pyocyanin inhibits the dual oxidase-based antimicrobial system as it imposes oxidative stress on airway epithelial cells. Rada B, Lekstrom K, Damian S, Dupuy C, Leto TL, J Immunol 2008 181 4883 4893 18802092
46. Pyocyanin alters redox homeostasis and carbon flux through central metabolic pathways in Pseudomonas aeruginosa PA14. Price-Whelan A, Dietrich LE, Newman DK, J Bacteriol 2007 189 6372 6381 10.1128/JB.00505-07 17526704 (Pubitemid 47378645)
47. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. Wilson R, Pitt T, Taylor G, Watson D, MacDermot J, Sykes D, Roberts D, Cole P, J Clin Invest 1987 79 221 229 10.1172/JCI112787 3098783 (Pubitemid 17232522)
48. Mechanism of pyocyanin- and 1-hydroxyphenazine-induced lung neutrophilia in sheep airways. Lauredo IT, Sabater JR, Ahmed A, Botvinnikova Y, Abraham WM, J Appl Physiol 1998 85 2298 2304 9843556 (Pubitemid 28558089)
49. Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. Usher LR, Lawson RA, Geary I, Taylor CJ, Bingle CD, Taylor GW, Whyte MKB, J Immunol 2002 168 1861 1868 11823520 (Pubitemid 34135787)
50. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, Brockhurst MA, Winstanley C, Am J Respir Crit Care Med 2011 183 1674 1679 10.1164/rccm.201009-1430OC 21297072
51. Phenazine-1-carboxylic acid, a secondary metabolite of Pseudomonas aeruginosa, alters expression of immunomodulatory proteins by human airway epithelial cells. Denning GM, Iyer SS, Reszka KJ, O'Malley Y, Rasmussen GT, Britigan BE, Am J Physiol Lung Cell Mol Physiol 2003 285 584 L592 12765878
52. Enhanced release of elastase and oxidative inactivation of alpha-1-protease inhibitor by stimulated human neutrophils exposed to Pseudomonas aeruginosa pigment 1-hydroxyphenazine. Ras GJ, Theron AJ, Anderson R, Taylor GW, Wilson R, Cole PJ, van der Merwe CA, J Infect Dis 1992 166 568 573 10.1093/infdis/166.3.568 1323622
53. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Wilson R, Sykes DA, Watson D, Rutman A, Taylor GW, Cole PJ, Infect Immun 1988 56 2515 2517 3137173
54. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. Fothergill JL, Panagea S, Hart CA, Walshaw MJ, Pitt TL, Winstanley C, BMC Microbiol 2007 7 45 10.1186/1471-2180-7-45 17521417 (Pubitemid 46903287)
55. Temperature-dependent expression of phzM and its regulatory genes lasI and ptsP in rhizosphere isolate Pseudomonas sp. strain M18. Huang J, Xu Y, Zhang H, Li Y, Huang X, Ren B, Zhang X, Appl Environ Microbiol 2009 75 6568 6580 10.1128/AEM.01148-09 19717631
56. Airway iron and iron-regulatory cytokines in cystic fibrosis. Reid DW, Lam QT, Schneider H, Walters EH, Eur Respir J 2004 24 286 291 10.1183/09031936.04.00104803 15332399 (Pubitemid 39139798)
57. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. Lamont IL, Konings AF, Reid DW, Biometals 2009 22 53 60 10.1007/s10534-008-9197-9 19130260
58. Transcriptome analysis of the Pseudomonas aeruginosa response to iron. Palma M, Worgall S, Quadri LE, Arch Microbiol 2003 180 374 379 10.1007/s00203-003-0602-z 14513207 (Pubitemid 37421520)
59. Transcriptome analyses and biofilm-forming characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung. Manos J, Arthur J, Rose B, Tingpej P, Fung C, Curtis M, Webb JS, Hu H, Kjelleberg S, Gorrell MD, et al. J Med Microbiol 2008 57 1454 1465 10.1099/jmm.0.2008/005009-0 19018014
60. Redefining penems. Dalhoff A, Janjic N, Echols R, Biochem Pharmacol 2006 71 1085 1095 10.1016/j.bcp.2005.12.003 16413506
61. Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis. Chamberland S, Bayer AS, Schollaardt T, Wong SA, Bryan LE, Antimicrob Agents Chemother 1989 33 624 634 2502066 (Pubitemid 19120001)
62. The major outer membrane protein OprG of Pseudomonas aeruginosa contributes to cytotoxicity and forms an anaerobically regulated, cation-selective channel. McPhee JB, Tamber S, Bains M, Maier E, Gellatly S, Lo A, Benz R, Hancock RE, FEMS Microbiol Lett 2009 296 241 247 10.1111/j.1574-6968. 2009.01651.x 19486157
63. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Aires JR, Kohler T, Nikaido H, Plesiat P, Antimicrob Agents Chemother 1999 43 2624 2628 10543738 (Pubitemid 29519539)
64. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Islam S, Oh H, Jalal S, Karpati F, Ciofu O, Hoiby N, Wretlind B, Clin Microbiol Infect 2009 15 60 66 19754760
65. Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa. Hocquet D, Nordmann P, El Garch F, Cabanne L, Plesiat P, Antimicrob Agents Chemother 2006 50 1347 1351 10.1128/AAC.50.4.1347-1351.2006 16569851
66. Effect of MexXY overexpression on ceftobiprole susceptibility in Pseudomonas aeruginosa. Baum EZ, Crespo-Carbone SM, Morrow BJ, Davies TA, Foleno BD, He W, Queenan AM, Bush K, Antimicrob Agents Chemother 2009 53 2785 2790 10.1128/AAC.00018-09 19433554
67. Genome-wide identification of Pseudomonas aeruginosa exported proteins using a consensus computational strategy combined with a laboratory-based PhoA fusion screen. Lewenza S, Gardy JL, Brinkman FSL, Hancock REW, Genome Res 2005 15 321 329 10.1101/gr.3257305 15687295 (Pubitemid 40309397)
68. Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: implications for inflammation in cystic fibrosis. Firoved AM, Ornatowski W, Deretic V, Infect Immun 2004 72 5012 5018 10.1128/IAI.72.9.5012-5018.2004 15321993 (Pubitemid 39223384)
69. A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa. Weimer ET, Lu H, Kock ND, Wozniak DJ, Mizel SB, Infect Immun 2009 77 2356 2366 10.1128/IAI.00054-09 19349426
70. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Ernst RK, Yi EC, Guo L, Lim KB, Burns JL, Hackett M, Miller SI, Science 1999 286 1561 1565 10.1126/science.286.5444.1561 10567263
71. The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway. Ernst RK, Adams KN, Moskowitz SM, Kraig GM, Kawasaki K, Stead CM, Trent MS, Miller SI, J Bacteriol 2006 188 191 201 10.1128/JB.188.1.191-201.2006 16352835
72. Review: lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. King JD, Kocincova D, Westman EL, Lam JS, Innate Immun 2009 15 261 312 10.1177/1753425909106436 19710102
73. Acyl homoserine-lactone quorum-sensing signal generation. Parsek MR, Val DL, Hanzelka BL, Cronan JE Jr, Greenberg EP, Proc Natl Acad Sci USA 1999 96 4360 4365 10.1073/pnas.96.8.4360 10200267 (Pubitemid 29190341)
74. Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis. Xia B, Royall JA, Damera G, Sachdev GP, Cummings RD, Glycobiology 2005 15 747 775 10.1093/glycob/cwi061 15994837 (Pubitemid 41430096)
75. Glycosylation of sputum mucins is altered in cystic fibrosis patients. Schulz BL, Sloane AJ, Robinson LJ, Prasad SS, Lindner RA, Robinson M, Bye PT, Nielson DW, Harry JL, Packer NH, Karlsson NG, Glycobiology 2007 17 698 712 10.1093/glycob/cwm036 17392389 (Pubitemid 47050659)
76. RNA expression profiling at the single molecule level. Hesse J, Jacak J, Kasper M, Regl G, Eichberger T, Winklmayr M, Aberger F, Sonnleitner M, Schlapak R, Howorka S, et al. Genome Res 2006 16 1041 1045 10.1101/gr.4999906 16809670 (Pubitemid 44162263)
77. iTRAQ underestimation in simple and complex mixtures: "the good, the bad and the ugly". Ow SY, Salim M, Noirel J, Evans C, Rehman I, Wright PC, J Proteome Res 2009 8 5347 5355 10.1021/pr900634c 19754192